Related Experiment Video
Updated: Aug 23, 2025

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
Published on: April 25, 2025
The Complement System: A Potential Therapeutic Target in Liver Cancer
Meng Yuan1, Li Liu2, Chenlin Wang1
1School of Clinical Medicine, Weifang Medical University, Weifang 261053, China.
The complement system influences liver cancer progression and may offer new therapeutic targets. Activating complement components shows promise for killing cancer cells and improving diagnosis.
Area of Science:
- Immunology
- Oncology
- Complement System Biology
Background:
- Liver cancer is a leading cause of cancer death globally.
- Current immunotherapies for liver cancer offer limited efficacy.
- Novel combinatorial strategies are needed for effective liver cancer treatment.
Purpose of the Study:
- To review the role of the complement system in liver cancer.
- To explore the complement system as a therapeutic target for liver cancer.
- To highlight the potential of complement activation in killing liver tumor cells.
Main Methods:
- Literature review of studies on the complement system and liver cancer.
- Analysis of complement's influence on tumor microenvironment, tumor cells, and cancer stem cells.
- Evaluation of complement activation as an anti-cancer strategy.
Main Results:
- The complement system modulates liver cancer progression through various mechanisms.
- Activation of complement components can directly kill liver cancer cells.
- The complement system connects innate and adaptive immunity in the context of cancer.
Conclusions:
- Complement components and regulators are potential biomarkers for liver cancer diagnosis.
- The complement system presents a promising therapeutic target for liver cancer treatment.
- Targeting the complement system offers a novel strategy for enhancing liver cancer therapy.
More Related Videos
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
07:25In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
Related Concept Videos
Complement System
Targeted Cancer Therapies
There are several types of targeted therapies against...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...